drugset / Trial / NCT03715114
A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects
RandomizedSequentialQuadruple-blindBasic science
Summary
To evaluate the safety and pharmacokinetics of GV-971 capsules after oral a single or multiple doses of 900 mg, 1200 mg and 1500 mg in healthy subjects.
Timeline
- Start
- 2018-10-15
- Primary completion
- 2018-11-30
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GV-971 | Other / unclassified | 900 mg | Oral |
| Subject | GV-971 | Other / unclassified | 1200 mg | Oral |
| Subject | GV-971 | Other / unclassified | 1500 mg | Oral |
Indications
No indication recorded.